Systemic exposure to fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Retroperitoneal Space Microsomes, Liver Liver Kidney Achilles Tendon

Organisms40

Streptococcus pneumoniae Macaca fascicularis Staphylococcus aureus Dogs Mycoplasma hominis Clostridium difficile Mycobacterium fortuitum Gram-Negative Bacteria Escherichia coli Pseudomonas aeruginosa Gram-Positive Bacteria Rats, Sprague-Dawley Mice, Inbred CBA Neisseria gonorrhoeae Salmonella typhi Laurus Bartonella bacilliformis Gram-Positive Cocci Mycobacterium tuberculosis Campylobacter Moraxella (Branhamella) catarrhalis Klebsiella pneumoniae Salmonella paratyphi A Salmonella enterica Bacteria, Anaerobic Enterobacteriaceae Mice, Knockout Bacteroides fragilis Campylobacter jejuni Bacteria Acinetobacter Campylobacter coli Haemophilus influenzae Shigella sonnei Mycoplasma bovis Mycobacterium smegmatis Stenotrophomonas maltophilia Salmonella Mice, Inbred C57BL Enterobacter cloacae

Diseases33

Dermatitis, Phototoxic Gram-Negative Bacterial Infections Neoplasms Pneumococcal Infections Bacterial Infections Typhoid Fever Community-Acquired Infections Urinary Tract Infections Neuroblastoma Escherichia coli Infections Enterocolitis, Pseudomembranous Paratyphoid Fever Cross Infection Precursor Cell Lymphoblastic Leukemia-Lymphoma Gram-Positive Bacterial Infections Otitis Externa Gonorrhea Respiratory Tract Infections Campylobacter Infections Extensively Drug-Resistant Tuberculosis Clostridium Infections Pseudomonas Infections Eye Infections, Bacterial Tuberculosis, Multidrug-Resistant Dermatitis, Photoallergic Staphylococcal Infections Klebsiella Infections Salmonella Infections Pneumonia, Bacterial Bacteremia Tendinopathy Enterobacteriaceae Infections Bronchitis, Chronic

Chemicals and Drugs73

Fluoroquinolones Anti-Infective Agents Ciprofloxacin Ofloxacin DNA Gyrase Aza Compounds Levofloxacin Anti-Bacterial Agents DNA Topoisomerase IV Quinolones Norfloxacin Pefloxacin Naphthyridines Quinolines Enoxacin 4-Quinolones Topotecan DNA Topoisomerases, Type II Prodrugs Teniposide Antineoplastic Agents, Phytogenic Organic Anion Transporters Acridines Topoisomerase I Inhibitors Nalidixic Acid Topoisomerase II Inhibitors Antineoplastic Agents Tetrahydroisoquinolines Ketoconazole Camptothecin Cytochrome P-450 CYP3A Macrolides Fleroxacin Tablets Cyclosporine beta-Lactams Pyrroles Paclitaxel Nitrofurantoin Aminoglycosides P-Glycoprotein DNA, Bacterial ATP-Binding Cassette Transporters Capreomycin Tacrolimus Antitubercular Agents Bacterial Proteins Pharmaceutical Preparations Immunosuppressive Agents Sulfonamides Anti-Infective Agents, Urinary Cephalosporins beta-Lactamases Trimethoprim-Sulfamethoxazole Combination Tetracyclines Carbapenems Enzyme Inhibitors Ethambutol Dioxolanes Lactams Protein Kinase Inhibitors Erythromycin Ketolides Minocycline Membrane Transport Proteins DNA Topoisomerases Rifampin Ethidium Streptogramin B Reserpine Tetracycline Chloramphenicol Azithromycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Area Under Curve Microbial Sensitivity Tests Administration, Oral Dry Powder Inhalers Metabolic Clearance Rate Biliopancreatic Diversion Infusions, Intravenous Cross-Over Studies Drug Administration Schedule Injections, Intravenous Chromatography, High Pressure Liquid Administration, Topical Maximum Tolerated Dose Administration, Inhalation Drug Monitoring Treatment Outcome Infusions, Intra-Arterial Models, Biological Chromatography, Liquid Tandem Mass Spectrometry Drug Delivery Systems Bayes Theorem Antineoplastic Combined Chemotherapy Protocols Transplantation, Heterologous Chromatography, Supercritical Fluid Serum Bactericidal Test Electrophoresis, Gel, Pulsed-Field Double-Blind Method Mass Spectrometry Ribotyping Colony Count, Microbial Prospective Studies Sequence Analysis, DNA

Phenomena and Processes25

Area Under Curve Biological Availability Drug Resistance, Bacterial Drug Resistance, Microbial Metabolic Clearance Rate Dose-Response Relationship, Drug Drug Resistance, Multiple, Bacterial Drug Interactions Half-Life Biotransformation Food-Drug Interactions Tissue Distribution Pharmacokinetics Maximum Tolerated Dose Skin Absorption Mutation Intestinal Absorption Drug Resistance, Multiple Time Factors Biological Transport beta-Lactam Resistance Genes, Bacterial Cephalosporin Resistance Methicillin Resistance Plasmids

Information Science1

Molecular Sequence Data

Health Care8

Area Under Curve Cross-Over Studies Treatment Outcome Drug Utilization Bayes Theorem Double-Blind Method Hospitals Prospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Health Care

Fluoroquinolones Anti-Infective Agents Ciprofloxacin Ofloxacin DNA Gyrase Area Under Curve Aza Compounds Levofloxacin Microbial Sensitivity Tests Anti-Bacterial Agents DNA Topoisomerase IV Quinolones Norfloxacin Biological Availability Drug Resistance, Bacterial Administration, Oral Pefloxacin Naphthyridines Quinolines Enoxacin Dry Powder Inhalers Drug Resistance, Microbial Metabolic Clearance Rate Dose-Response Relationship, Drug 4-Quinolones Topotecan Biliopancreatic Diversion Drug Resistance, Multiple, Bacterial DNA Topoisomerases, Type II Drug Interactions Half-Life Prodrugs Streptococcus pneumoniae Infusions, Intravenous Teniposide Dermatitis, Phototoxic Cross-Over Studies Drug Administration Schedule Antineoplastic Agents, Phytogenic Biotransformation Organic Anion Transporters Food-Drug Interactions Acridines Topoisomerase I Inhibitors Injections, Intravenous Nalidixic Acid Chromatography, High Pressure Liquid Topoisomerase II Inhibitors Antineoplastic Agents Tissue Distribution Gram-Negative Bacterial Infections Neoplasms Tetrahydroisoquinolines Ketoconazole Administration, Topical Camptothecin Macaca fascicularis Pharmacokinetics Cytochrome P-450 CYP3A Maximum Tolerated Dose Macrolides Fleroxacin Tablets Staphylococcus aureus Cyclosporine Dogs Mycoplasma hominis Skin Absorption beta-Lactams Clostridium difficile Pyrroles Pneumococcal Infections Mutation Retroperitoneal Space Bacterial Infections Paclitaxel Typhoid Fever Mycobacterium fortuitum Administration, Inhalation Gram-Negative Bacteria Escherichia coli Nitrofurantoin Intestinal Absorption Aminoglycosides P-Glycoprotein Drug Monitoring Pseudomonas aeruginosa Treatment Outcome DNA, Bacterial ATP-Binding Cassette Transporters Gram-Positive Bacteria Capreomycin Tacrolimus Community-Acquired Infections Antitubercular Agents Drug Resistance, Multiple Infusions, Intra-Arterial Drug Utilization Urinary Tract Infections Neuroblastoma

No FAQ available that match "systemic exposure to fluoroquinolones"